ERα is regarded as the one of the main targets responsible for the anti-obesity effects of E2 based on its expression levels in human subcutaneous WAT [74] as well as the results of a study using E2 inhibitor [75]. The gene discussed is ESR1; the disease is obesity due to melanocortin 4 receptor deficiency.